BLFS
BioLife Solutions, Inc.
About BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services to the cell and gene therapy (CGT) industry and the broader biopharma market. Its products are used in basic and applied research and commercial manufacturing of biologic-based therapies. It has a portfolio of tools and services that focus on biopreservation, cell processing, frozen biologic storage products and services, cold-chain transportation, and thawing of biologic materials. Its tools portfolio includes its CryoStor and HypoThermosol biopreservation media for shipping and storage, the ThawSTAR family of automated, water-free thawing products, evo cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. Customers use its products to maintain the health and function of biologic material during sourcing, manufacturing, storage, and distribution.
Buy US stocks in Australia starting with BLFS. Open an account and start investing today!
$1.02B
-
0.00%
279.25K
$24.15
$23.37
$23.73
$31.11
$10.40
BLFS FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in BLFS
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.